234 related articles for article (PubMed ID: 32063105)
1. Very high-dose methylprednisolone for treatment of nivolumab-induced limbic encephalitis: A case report.
Taillefer VT; Pigeon M; Chen M; Larochelle C; Florescu M; Bélanger K; Adam JP
J Oncol Pharm Pract; 2020 Sep; 26(6):1538-1543. PubMed ID: 32063105
[TBL] [Abstract][Full Text] [Related]
2. Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment.
Bir Yucel K; Sutcuoglu O; Yazıcı O; Yıldız Y; Şenol E; Uner A
J Oncol Pharm Pract; 2023 Apr; 29(3):760-763. PubMed ID: 35938177
[TBL] [Abstract][Full Text] [Related]
3. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
[TBL] [Abstract][Full Text] [Related]
4. Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis.
Larkin J; Chmielowski B; Lao CD; Hodi FS; Sharfman W; Weber J; Suijkerbuijk KPM; Azevedo S; Li H; Reshef D; Avila A; Reardon DA
Oncologist; 2017 Jun; 22(6):709-718. PubMed ID: 28495807
[TBL] [Abstract][Full Text] [Related]
5. GAD65 autoimmunity after treatment with nivolumab: a multifocal presentation.
Maniscalco GT; Zekeridou A; Allegorico L; Ranieri A; Napolitano M; Pezzella M; Gatta LD; Manzo V; Ferrari S; Mariotto S
Neurol Sci; 2021 Oct; 42(10):4289-4291. PubMed ID: 33977307
[TBL] [Abstract][Full Text] [Related]
6. Delayed immune thrombocytopenia after discontinuation of nivolumab therapy: A case report and literature review.
Fu S; Wang T; Xu F
J Oncol Pharm Pract; 2021 Sep; 27(6):1548-1552. PubMed ID: 33435825
[TBL] [Abstract][Full Text] [Related]
7. Interstitial granulomatous dermatitis and concurrent immunotherapy associated encephalitis with nivolumab and ipilimumab.
Starling CT; Messer AA; Kleiman A; McQuade JL; Glitza IC; Torres-Cabala CA; Heberton M
Dermatol Online J; 2022 Mar; 28(2):. PubMed ID: 35670686
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review.
Sise ME; Seethapathy H; Reynolds KL
Oncologist; 2019 Jun; 24(6):735-742. PubMed ID: 30902916
[TBL] [Abstract][Full Text] [Related]
9. Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer.
Williams TJ; Benavides DR; Patrice KA; Dalmau JO; de Ávila AL; Le DT; Lipson EJ; Probasco JC; Mowry EM
JAMA Neurol; 2016 Aug; 73(8):928-33. PubMed ID: 27271951
[TBL] [Abstract][Full Text] [Related]
10. Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report.
Kopecký J; Kubeček O; Geryk T; Slováčková B; Hoffmann P; Žiaran M; Priester P
J Med Case Rep; 2018 Sep; 12(1):262. PubMed ID: 30217214
[TBL] [Abstract][Full Text] [Related]
11. Nivolumab-Associated Acute Demyelinating Encephalitis: A Case Report and Literature Review.
Zafar Z; Vogler C; Hudali T; Bhattarai M
Clin Med Res; 2019 Jun; 17(1-2):29-33. PubMed ID: 31160476
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint inhibitor induced anti-glutamic acid decarboxylase 65 (Anti-GAD 65) limbic encephalitis responsive to intravenous immunoglobulin and plasma exchange.
Chung M; Jaffer M; Verma N; Mokhtari S; Ramsakal A; Peguero E
J Neurol; 2020 Apr; 267(4):1023-1025. PubMed ID: 31832829
[TBL] [Abstract][Full Text] [Related]
13. Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports.
Yoshino K; Nakayama T; Ito A; Sato E; Kitano S
BMC Cancer; 2019 Oct; 19(1):1019. PubMed ID: 31664934
[TBL] [Abstract][Full Text] [Related]
14. Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature.
Kosche C; Stout M; Sosman J; Lukas RV; Choi JN
Melanoma Res; 2020 Jun; 30(3):313-316. PubMed ID: 31567590
[TBL] [Abstract][Full Text] [Related]
15. [Successful use of methylprednisolone therapy in a case of non-herpetic acute encephalitis with antibodies against ionotropic glutamate receptor epsilon2 and delta2].
Wada Y; Takahashi R; Yanagihara C; Nishimura Y; Takahashi Y
Brain Nerve; 2007 May; 59(5):527-32. PubMed ID: 17533979
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune encephalitis related to nivolumab followed by tumor regression.
Mysler SJ; Perazzo F; Mandó P
Medicina (B Aires); 2023; 83(3):479-483. PubMed ID: 37379548
[TBL] [Abstract][Full Text] [Related]
17. [Autoimmune limbic encephalitis: importance of early diagnosis and treatment].
van Vliet J; Meulstee J; Hartong EG; Mulleners WM
Ned Tijdschr Geneeskd; 2012; 156(16):A4455. PubMed ID: 22510418
[TBL] [Abstract][Full Text] [Related]
18. Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma.
Gao CA; Weber UM; Peixoto AJ; Weiss SA
J Immunother Cancer; 2019 Oct; 7(1):262. PubMed ID: 31623673
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of a Low-dose Corticosteroid in a Patient with Polymyalgia Rheumatica Associated with Nivolumab Treatment].
Imai Y; Tanaka M; Fujii R; Uchitani K; Okazaki K
Yakugaku Zasshi; 2019; 139(3):491-495. PubMed ID: 30828027
[TBL] [Abstract][Full Text] [Related]
20. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
Afzal MZ; Mabaera R; Shirai K
J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
